EUVIMEDOpdag EUVIMED
Systematische ÜbersichtMetaanalyseOpen access · CC BY-NC-ND 4.0

Characteristics of Hearing Loss in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis

Merkmale von Hörverlust bei Typ-2-Diabetes mellitus: systematische Übersichtsarbeit und Metaanalyse

Cory Hyun-Su Kim, Katherine L Lauritsen, Shaun A Nguyen iD, Ted A Meyer, Evan C Cumpston, Justin Pelic, Robert Labadie

Otolaryngology–Head and Neck Surgery · 2025-12 · 173 (6) · 1317-1327

DOI: 10.1002/ohn.1378 ↗

Auf einen Blick

39 Studien zeigen bei Menschen mit Typ-2-Diabetes häufiger klinisch relevanten Hörverlust als bei Kontrollen (53,0 % vs. 25,2 %).

Fragestellung

Wie häufig tritt Hörverlust bei Typ-2-Diabetes mellitus auf, und wie unterscheidet er sich von Kontrollen?

Methode

Systematische Übersichtsarbeit und Metaanalyse nach PRISMA; Datenbanken CINAHL, Cochrane Library, PubMed und SCOPUS.

Ergebnisse

39 Studien mit 88.395 Patient:innen mit T2DM und 20.337 Kontrollen. Klinisch relevanter Hörverlust: 53,0 % vs. 25,2 %; ∆ = 27,7 %, p < .0001; RR = 2,3 (95 %-KI 1,1–4,8).

Schlussfolgerung der Autor:innen

Die Metaanalyse liefert aktualisierte Schätzungen zu Prävalenz und relativem Risiko von Hörverlust bei T2DM sowie zu Klassifikation, Lateralisierung und Schweregrad.

Kernaussagen

  • Hörverlust war bei T2DM häufiger als bei Kontrollen.
  • RR für klinisch relevanten Hörverlust: 2,3 (95 %-KI 1,1–4,8).
  • Auch Schweregrad und Lateralisierung wurden beschrieben.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Systematische Übersicht in Otolaryngology–Head and Neck Surgery, published online on 2025-08-04. Written by Cory Hyun-Su Kim and 6 co-authors. Institution: Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA. Major MEDLINE topics: Diabetes Mellitus, Type 2, Hearing Loss. Cited 13 times so far (Crossref); 67 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

Auf einen BlickAbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Methods

A systematic review of CINAHL, Cochrane Library, PubMed, and SCOPUS databases was conducted according to PRISMA guidelines to identify studies evaluating T2DM and hearing loss. Primary outcome measures included continuous measures (mean), proportions (%), proportional difference ( ∆ ), and relative risks (RR) with 95% confidence intervals (CI).

Results

A total of 39 studies with 88,395 patients with T2DM and 20,337 controls were included. The mean ages of the T2DM and control groups were 50.3 (range: 19‐96) and 46.7 (range: 19‐76), respectively, with females comprising 63.8% and 64.3% of the groups. The mean duration of diabetes in the T2DM group was 9.1 years (95% CI: 8.1‐10.1), and mean HbA1c of 8.4% (95% CI: 8.1‐8.6), while the control group had 4.8% (95% CI: 3.9‐5.7). Patients with T2DM had significantly higher prevalence and relative risk of clinically significant hearing loss compared to controls (53.0% vs 25.2%; ∆ = 27.7%, p < .0001; RR = 2.3, 95% CI: 1.1‐4.8). In T2DM, 5.0% had conductive, 46.2% sensorineural, and 10.4% mixed hearing loss. According to WHO criteria, the T2DM group exhibited 22.1% mild (26‐40 dB), 25.5% moderate (41‐60 dB), 8.5% severe (61‐80 dB), and 1.7% profound (>80 dB) hearing loss all with statistically significant differences compared controls ( p ≤ .0001). In the T2DM group, data on laterality showed 15.0% unilateral and 29.6% bilateral hearing loss, both significantly higher than the controls ( p = .008, p < .0001).

Conclusion

This meta‐analysis provides most updated estimates of the prevalence and relative risk of hearing loss in patients with T2DM, including details on the classification, laterality, and degrees. The significantly increased risk highlights the importance of incorporating hearing assessments and management into routine care for patients with T2DM.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 2Hearing LossHumans

Author keywords

NIDDMT2DMhearing deficiencyhearing difficultyhearing lossnon‐insulin dependent diabetes mellitustype 2 diabetes mellitus

Authors and institutions

  • Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Nova Southeastern University-School of Osteopathic Medicine, Clearwater, Florida, USA.
  • Department of Otolaryngology-Head and Neck Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Rutgers, New Jersey Medical School, Newark, New Jersey, USA.

ORCID profiles: Shaun A Nguyen

Cite

APA

Kim, C. H., Lauritsen, K. L., Nguyen, S. A., Meyer, T. A., Cumpston, E. C., Pelic, J., & Labadie, R. (2025). Characteristics of Hearing Loss in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis. Otolaryngology–Head and Neck Surgery, 173(6), 1317-1327. https://doi.org/10.1002/ohn.1378

Vancouver

Kim CH, Lauritsen KL, Nguyen SA, Meyer TA, Cumpston EC, Pelic J, et al. Characteristics of Hearing Loss in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis. Otolaryngology–Head and Neck Surgery. 2025;173(6):1317-1327. doi:10.1002/ohn.1378

BibTeX
@article{Kim2025,
  author = {Kim, Cory Hyun-Su and Lauritsen, Katherine L and Nguyen, Shaun A and Meyer, Ted A and Cumpston, Evan C and Pelic, Justin and Labadie, Robert},
  title = {Characteristics of Hearing Loss in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2025},
  volume = {173},
  number = {6},
  pages = {1317--1327},
  doi = {10.1002/ohn.1378}
}
Start for free →